These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 7028552)
1. Diabetic control in patients treated with once or twice-daily insulin injections, including a comparison of conventional beef and highly purified pork insulins. Gray RS; Borsey DQ; Fraser DM; Kurtz AB; Rainbow S; Smith AF; Duncan LJ; Clarke BF Diabetologia; 1981 Sep; 21(3):206-10. PubMed ID: 7028552 [TBL] [Abstract][Full Text] [Related]
2. Effects of new insulins on insulin and C-peptide antibodies, insulin dose, and diabetic control. Peacock I; Tattersall RB; Taylor A; Douglas CA; Reeves WG Lancet; 1983 Jan; 1(8317):149-52. PubMed ID: 6130198 [TBL] [Abstract][Full Text] [Related]
3. Decrease of antibodies to insulin, proinsulin and contaminating hormones after changing treatment from conventional beef to purified pork insulin. Kurtz AB; Matthews JA; Mustaffa BE; Daggett PR; Nabarro JD Diabetologia; 1980; 18(2):147-50. PubMed ID: 6988274 [TBL] [Abstract][Full Text] [Related]
4. A clinical comparison of purified bovine and purified porcine insulins. Olczak SA; Greenwood RH Postgrad Med J; 1985 Jan; 61(711):15-8. PubMed ID: 3887349 [TBL] [Abstract][Full Text] [Related]
5. The production and characteristics of anti-insulin, anti-A-component and anti-proinsulin antibodies in patients treated with monocomponent or conventional insulin. Kawazu S; Kanazawa Y; Miki E; Hayashi M; Sando H; Kajinuma H; Iwamoto Y; Akanuma Y; Kosaka K Acta Diabetol Lat; 1979; 16(4):339-51. PubMed ID: 399151 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of highly purified bovine insulin: a comparison with conventional bovine and highly purified human insulins. Wilson RM; Douglas CA; Tattersall RB; Reeves WG Diabetologia; 1985 Sep; 28(9):667-70. PubMed ID: 3905477 [TBL] [Abstract][Full Text] [Related]
7. Relationship of glycosylated haemoglobin to C-peptide secretory status and antibody binding of insulin in insulin-dependent diabetes. Gray RS; Borsey DQ; Kurtz A; Rainbow S; Smith AF; Elton RA; Duncan LJ; Clarke BF Horm Metab Res; 1981 Nov; 13(11):599-603. PubMed ID: 7030898 [TBL] [Abstract][Full Text] [Related]
8. The effect of insulin antibodies on insulin dose and diabetic control. Walford S; Allison SP; Reeves WG Diabetologia; 1982 Feb; 22(2):106-10. PubMed ID: 7037511 [TBL] [Abstract][Full Text] [Related]
9. Circulating antibodies in diabetics treated with conventional and purified insulins. Klaff LJ; Vinik AI; Berelowitz M; Jackson WP S Afr Med J; 1978 Jul; 54(4):149-53. PubMed ID: 694712 [TBL] [Abstract][Full Text] [Related]
10. Change of insulin dosage, circulating free and bound insulin and insulin antibodies on transferring diabetics from conventional to highly purified porcine insulin. Asplin CM; Hartog M; Goldie DJ Diabetologia; 1978 Feb; 14(2):99-105. PubMed ID: 631462 [TBL] [Abstract][Full Text] [Related]
11. Circulating insulin antibodies during therapy with highly purified neutrally buffered insulins including desphe insulins. Report of a prospective study with 40 cases. Kühnau J; Rüdiger H; Goetz K Exp Clin Endocrinol; 1984 Apr; 83(2):161-7. PubMed ID: 6373318 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of highly purified porcine and human insulins in diabetic patients with high titers of insulin antibody. Lam HC; Ho LT; Tang KT; Wang LM; Kwok CF; Liu YF; Hsiao LJ; Li SH Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):346-51. PubMed ID: 2677227 [TBL] [Abstract][Full Text] [Related]
14. Insulin binding capacity in patients changed from conventional to highly purified insulins. An indicator of likely response. Mustaffa BE; Daggett PR; Nabarro JD Diabetologia; 1977 Aug; 13(4):311-5. PubMed ID: 562300 [TBL] [Abstract][Full Text] [Related]
15. Effects of species of origin, purification levels, and formulation on insulin immunogenicity. Fineberg SE; Galloway JA; Fineberg NS; Goldman J Diabetes; 1983 Jul; 32(7):592-9. PubMed ID: 6345238 [TBL] [Abstract][Full Text] [Related]
16. Subpopulations of antibodies directed against evolutionarily conserved regions of the insulin molecule in insulin-treated patients. Karlsson F; Harrison LC; Kahn CR; Itin A; Roth J Diabetologia; 1982 Dec; 23(6):488-93. PubMed ID: 6759274 [TBL] [Abstract][Full Text] [Related]
17. Correlation between HbA1c, purified insulins, diabetic control, and insulin antibodies in diabetic children. Bistritzer T; Sack J; Theodor R; Weissglass L; Ben-Bassat I; Lahav M Horm Res; 1984; 20(3):178-85. PubMed ID: 6386647 [TBL] [Abstract][Full Text] [Related]
18. Metabolic control in diabetic patients. Effect of insulin-secretory reserve (measured by plasma C-peptide levels) and circulating insulin antibodies. Gonen B; Goldman J; Baldwin D; Goldberg RB; Ryan WG; Blix PM; Schanzlin D; Fritz KJ; Rubenstein AH Diabetes; 1979 Aug; 28(8):749-53. PubMed ID: 446933 [TBL] [Abstract][Full Text] [Related]
19. Comparison of two twice-daily insulin regimens: ultralente/soluble and soluble/isophane. Ward GM; Simpson RW; Ward EA; Turner RC Diabetologia; 1981 Oct; 21(4):383-6. PubMed ID: 7026334 [TBL] [Abstract][Full Text] [Related]
20. Twice-daily insulin regimens in management of severe diabetes. Oakley N; Mather H; Hadley L; Lynch J; Pilkington T J R Soc Med; 1981 May; 74(5):363-7. PubMed ID: 7017138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]